Completed PHASE4 INTERVENTIONAL 2-arm NCT01158443

Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS

Sponsor: Research Foundation for Mental Hygiene, Inc.

Interventions Behavioral Activation Therapy Supportive Counseling

Updated 6 times since 2017 Last updated: Dec 19, 2016 Started: Jul 31, 2010 Primary completion: Dec 31, 2013 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01158443, this PHASE4 trial focuses on Fatigue and Goals and remains completed. Sponsored by Research Foundation for Mental Hygiene, Inc., it has been updated 6 times since 2010, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Research Foundation for Mental Hygiene, Inc.

Data source: Research Foundation for Mental Hygiene, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States